March 23, 2020 / 9:49 PM / 12 days ago

BRIEF-Cumberland Pharmaceuticals Inc - Initiative Designed To Help Address Potential Antibiotic Shortages

Cumberland Pharmaceuticals Inc:

* CUMBERLAND PHARMACEUTICALS ANNOUNCES INITIATIVE TO EXPAND AVAILABILITY OF VIBATIV® TO TREAT HOSPITAL-ACQUIRED & VENTILATOR-ASSOCIATED PNEUMONIA RESULTING FROM CORONAVIRUS INFECTIONS

* CUMBERLAND PHARMACEUTICALS INC - INITIATIVE DESIGNED TO HELP ADDRESS POTENTIAL ANTIBIOTIC SHORTAGES

* CUMBERLAND PHARMACEUTICALS INC - RESPONSE TO COVID-19 CRISIS INCLUDES SPECIAL SUPPLY ARRANGEMENTS FOR U.S. HOSPITALS

* CUMBERLAND PHARMA - FINANCIAL ARRANGEMENTS BEING OFFERED BY CUMBERLAND INCLUDE EXTENDED PAYMENT TERMS FOR DIRECT ACCOUNT PURCHASES OF VIBATIV Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below